FIELD: biotechnology.
SUBSTANCE: invention relates to organic chemistry, namely to a new heterocyclic compound [RD93], which may be useful for treatment of hormone-refractory prostate cancer, benign prostatic hyperplasia, breast cancer and ovarian cancer.
EFFECT: new heterocyclic compound with useful biological properties is obtained.
6 cl, 41 dwg, 11 tbl, 61 ex
Authors
Dates
2017-12-18—Published
2011-12-23—Filed